tiprankstipranks
ADMA Biologics (ADMA)
NASDAQ:ADMA
US Market

ADMA Biologics (ADMA) Financial Statements

2,448 Followers

ADMA Biologics Financial Overview

ADMA Biologics's market cap is currently ―. The company's EPS TTM is $-0.02; its P/E ratio is -654.90; ADMA Biologics is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $0.08. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 81.88M$ 73.90M$ 67.27M$ 60.12M$ 56.91M
Gross Profit$ 39.11M$ 31.09M$ 24.65M$ 16.69M$ 16.51M
EBIT$ 22.16M$ -24.75M$ 8.94M$ -92.76K$ -5.33M
EBITDA$ 24.49M$ -21.98M$ 11.72M$ 2.66M$ -2.85M
Net Income Common Stockholders$ 17.81M$ -17.58M$ 2.54M$ -6.37M$ -6.81M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 45.33M$ 51.35M$ 74.16M$ 62.51M$ 69.20M
Total Assets$ 350.88M$ 329.18M$ 349.00M$ 343.00M$ 340.79M
Total Debt$ 141.43M$ 141.42M$ 152.97M$ 151.51M$ 155.73M
Net Debt$ 96.10M$ 90.07M$ 78.82M$ 89.00M$ 86.52M
Total Liabilities$ 197.17M$ 193.98M$ 197.56M$ 196.26M$ 195.13M
Stockholders Equity$ 153.71M$ 135.21M$ 151.44M$ 146.76M$ 145.65M
Cash Flow-
Free Cash Flow$ -4.58M$ 16.19M$ 11.23M$ -6.93M$ -16.67M
Operating Cash Flow$ -2.22M$ 17.60M$ 11.99M$ -6.06M$ -14.72M
Investing Cash Flow$ -2.36M$ -1.41M$ -756.56K$ -872.63K$ -1.94M
Financing Cash Flow$ -1.45M$ -38.99M$ 415.36K$ 240.12K$ -650.51K
Currency in USD

ADMA Biologics Earnings and Revenue History

ADMA Biologics Debt to Assets

ADMA Biologics Cash Flow

ADMA Biologics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis